Health & Fitness
Tue, September 4, 2012Mon, September 3, 2012Sun, September 2, 2012Sat, September 1, 2012Fri, August 31, 2012Thu, August 30, 2012Wed, August 29, 2012Tue, August 28, 2012Mon, August 27, 2012Sun, August 26, 2012Sat, August 25, 2012Fri, August 24, 2012Thu, August 23, 2012Wed, August 22, 2012Tue, August 21, 2012Mon, August 20, 2012Vermillion to Present at the 2012 Gateway Conference on September 6
Published in Health and Fitness on Tuesday, August 28th 2012 at 10:48 GMT by Market Wire
Vermillion to Present at the 2012 Gateway Conference on September 6 -- AUSTIN, Texas, Aug. 28, 2012 /PRNewswire/ --
Vermillion to Present at the 2012 Gateway Conference on September 6
AUSTIN, Texas, Aug. 28, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: [ VRML ]), a leading molecular diagnostics company, has been invited to present at the 2012 Gateway Conference being held on September 6 at the W San Francisco Hotel.
Vermillion management is scheduled to present at 11:00 a.m. Pacific time, with one-on-one meetings held throughout the day. As the first FDA-cleared blood test for pre-surgical cancer diagnosis of ovarian tumors by using a unique multi-biomarker approach, management will discuss the company's progress in making OVA1® the standard of care in the diagnosis of ovarian cancer.
To schedule a one-on-one meeting, visit [ www.gateway-conference.com ] and click on the Register/Login tab. You may also email your request to [ schedule@gateway-conference.com ] or call Ron Both at (949) 574-3860.
About the Gateway Conference
Gateway Conference is designed to provide a unique gateway between influential members of the investment community and a select group of compelling publicly-traded companies. Portfolio managers, research analysts and brokers from buy-side and sell-side institutions will have the opportunity to learn about more than 50 emerging growth companies across a broad range of industries, from technology, business services and digital media, to clean-tech, consumer/retail, life sciences and natural resources. For more information, go to [ www.gateway-conference.com ].
The invitation-only conference is hosted by Liolios Group, one of the nation's top investor relations agencies, and sponsored by leading firms that service the financial community. For more information about Liolios Group, visit [ www.liolios.com ].
About Vermillion
Vermillion, Inc. (NASDAQ: [ VRML ]) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional information about Vermillion can be found at [ www.vermillion.com ].
Investor Relations Contact:
Liolios Group
Scott Liolios or Ron Both
Tel 949-574-3860
[ vrml@liolios.com ]
SOURCE Vermillion, Inc.
[ Back to top ]
RELATED LINKS
[ http://www.vermillion.com ]
